| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 119, 375-380, Copyright © 1986 by Endocrine Society
ARTICLES |
M Konagaya, PA Bernard and SR Max
Glucocorticoid hormones cause marked muscular atrophy, the mechanism of which is unknown. We employed a potent glucocorticoid antagonist, RU38486 [11 beta-(4-dimethylaminophenyl)17 beta-hydroxy-17 alpha-(prop- 1-ynyl)estra-4,9-dien-3-one], to determine whether intracellular glucocorticoid receptors are involved. RU38486 was shown to be an effective blocker of glucocorticoid receptor binding in vivo and in vitro. Furthermore, this compound significantly blocked the loss of body and muscle weight caused by injection of dexamethasone. These data indicate that intracellular glucocorticoid receptors are important in the etiology of steroid myopathy. Studies with glucocorticoid antagonists may lead to the design of specific therapeutic modalities for the treatment of both endogenously and exogenously produced steroid myopathies.
This article has been cited by other articles:
![]() |
H. Gilson, O. Schakman, L. Combaret, P. Lause, L. Grobet, D. Attaix, J. M. Ketelslegers, and J. P. Thissen Myostatin Gene Deletion Prevents Glucocorticoid-Induced Muscle Atrophy Endocrinology, January 1, 2007; 148(1): 452 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Schakman, H. Gilson, V. de Coninck, P. Lause, J. Verniers, X. Havaux, J. M. Ketelslegers, and J. P. Thissen Insulin-Like Growth Factor-I Gene Transfer by Electroporation Prevents Skeletal Muscle Atrophy in Glucocorticoid-Treated Rats Endocrinology, April 1, 2005; 146(4): 1789 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Walsh, J. M. Zmuda, J. A. Cauley, P. R. Shea, E. J. Metter, B. F. Hurley, R. E. Ferrell, and S. M. Roth Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men J Appl Physiol, January 1, 2005; 98(1): 132 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun, C. Wray, X. Tian, P.-O. Hasselgren, and J. Lu Expression of uncoupling protein 3 is upregulated in skeletal muscle during sepsis Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E512 - E520. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Pickering, F. E. Baker, J. Brown, H. L. Butler, S. Govindji, J. M. Parsons, I. Z. A. Pawluczyk, J. Walls, and A. Bevington Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1475 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Pickering, F. E. Baker, J. Brown, H. L. Butler, S. Govindji, J. M. Parsons, I. Z. A. Pawluczyk, J. Walls, and A. Bevington Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1475 - 1484. [Abstract] [Full Text] |
||||
![]() |
K. Ma, C. Mallidis, S. Bhasin, V. Mahabadi, J. Artaza, N. Gonzalez-Cadavid, J. Arias, and B. Salehian Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E363 - E371. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Eason, S. L Dodd, and S. K Powers Use of Anabolic Steroids to Attenuate the Effects Glucocorticoids on the Rat Diaphragm Physical Therapy, January 1, 2003; 83(1): 29 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. De Jonghe, T. Sharshar, J.-P. Lefaucheur, F.-J. Authier, I. Durand-Zaleski, M. Boussarsar, C. Cerf, E. Renaud, F. Mesrati, J. Carlet, et al. Paresis Acquired in the Intensive Care Unit: A Prospective Multicenter Study JAMA, December 11, 2002; 288(22): 2859 - 2867. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Eason, S. L Dodd, S. K Powers, and A D. Martin Detrimental Effects of Short-term Glucocorticoid Use on the Rat Diaphragm Physical Therapy, February 1, 2000; 80(2): 160 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chrysis and L. E. Underwood Regulation of Components of the Ubiquitin System by Insulin-Like Growth Factor I and Growth Hormone in Skeletal Muscle of Rats Made Catabolic with Dexamethasone Endocrinology, December 1, 1999; 140(12): 5635 - 5641. [Abstract] [Full Text] |
||||
![]() |
R. Minet-Quinard, C. Moinard, F. Villie, S. Walrand, M.-P. Vasson, J. Chopineau, and L. Cynober Kinetic impairment of nitrogen and muscle glutamine metabolisms in old glucocorticoid-treated rats Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E558 - E564. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Sieck, R. H. H. Van Balkom, Y. S. Prakash, W.-Z. Zhan, and P. N. R. Dekhuijzen Corticosteroid effects on diaphragm neuromuscular junctions J Appl Physiol, January 1, 1999; 86(1): 114 - 122. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |